FR2856685B1 - Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
FR2856685B1
FR2856685B1 FR0307670A FR0307670A FR2856685B1 FR 2856685 B1 FR2856685 B1 FR 2856685B1 FR 0307670 A FR0307670 A FR 0307670A FR 0307670 A FR0307670 A FR 0307670A FR 2856685 B1 FR2856685 B1 FR 2856685B1
Authority
FR
France
Prior art keywords
preparing
processes
pharmaceutical compositions
compositions containing
thiazolylpiperidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0307670A
Other languages
English (en)
Other versions
FR2856685A1 (fr
Inventor
Philippe Guedat
Francois Collonges
Herve Dumas
Jean Yves Ortholand
Jacques Decerprit
Jacques Barbanton
Richard J Foster
Peter Kane
Bernd Wendt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
Merck Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0307670A priority Critical patent/FR2856685B1/fr
Application filed by Merck Sante SAS filed Critical Merck Sante SAS
Priority to BRPI0411721-2A priority patent/BRPI0411721A/pt
Priority to CA2531011A priority patent/CA2531011C/fr
Priority to US10/561,989 priority patent/US7674803B2/en
Priority to AT04735742T priority patent/ATE426599T1/de
Priority to DE602004020223T priority patent/DE602004020223D1/de
Priority to JP2006515818A priority patent/JP4629666B2/ja
Priority to ES04735742T priority patent/ES2323463T3/es
Priority to KR1020057024663A priority patent/KR20060024812A/ko
Priority to AU2004253649A priority patent/AU2004253649B2/en
Priority to MXPA05013521A priority patent/MXPA05013521A/es
Priority to PCT/EP2004/005931 priority patent/WO2005003128A1/fr
Priority to RU2006101890/04A priority patent/RU2006101890A/ru
Priority to EP04735742A priority patent/EP1636218B1/fr
Priority to CNA2004800157394A priority patent/CN1809560A/zh
Priority to TW093117985A priority patent/TW200518751A/zh
Priority to ARP040102230A priority patent/AR044909A1/es
Publication of FR2856685A1 publication Critical patent/FR2856685A1/fr
Application granted granted Critical
Publication of FR2856685B1 publication Critical patent/FR2856685B1/fr
Priority to ZA200600690A priority patent/ZA200600690B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR0307670A 2003-06-25 2003-06-25 Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent Expired - Fee Related FR2856685B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR0307670A FR2856685B1 (fr) 2003-06-25 2003-06-25 Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2004/005931 WO2005003128A1 (fr) 2003-06-25 2004-06-02 Derives de la thiazolylpiperidine, inhibiteurs de la mtp
US10/561,989 US7674803B2 (en) 2003-06-25 2004-06-02 Thiazolypiperidine derivatives as MTP inhibitors
AT04735742T ATE426599T1 (de) 2003-06-25 2004-06-02 Thiazolylpiperidin derivate als mtp inhibitoren
DE602004020223T DE602004020223D1 (de) 2003-06-25 2004-06-02 Thiazolylpiperidin derivate als mtp inhibitoren
JP2006515818A JP4629666B2 (ja) 2003-06-25 2004-06-02 ｍｔｐ阻害剤としてのチアゾリルピペリジン誘導体
ES04735742T ES2323463T3 (es) 2003-06-25 2004-06-02 Derivados de tiazolilpiperidina como inhibidores de la mtp.
KR1020057024663A KR20060024812A (ko) 2003-06-25 2004-06-02 Ｍｔｐ 저해제로서의 티아졸일피페리딘 유도체
AU2004253649A AU2004253649B2 (en) 2003-06-25 2004-06-02 Thiazolylpiperidine derivatives as MTP inhibitors
EP04735742A EP1636218B1 (fr) 2003-06-25 2004-06-02 Derives de la thiazolylpiperidine, inhibiteurs de la mtp
BRPI0411721-2A BRPI0411721A (pt) 2003-06-25 2004-06-02 derivados de tiazolilpiperidina como inibidores de mtp
CA2531011A CA2531011C (fr) 2003-06-25 2004-06-02 Derives de la thiazolylpiperidine, inhibiteurs de la mtp
MXPA05013521A MXPA05013521A (es) 2003-06-25 2004-06-02 Derivados de tiazolilpiperidina como inhibidores de mtp.
CNA2004800157394A CN1809560A (zh) 2003-06-25 2004-06-02 作为mtp抑制剂的噻唑基哌啶衍生物
RU2006101890/04A RU2006101890A (ru) 2003-06-25 2004-06-02 Производные тиазолилпиперидина в качестве ингибиторов мпб
TW093117985A TW200518751A (en) 2003-06-25 2004-06-21 Thiazolylpiperidine derivatives, processes for the preparation thereof, pharmaceutical compositions comprising same, and applications thereof in the tre atment of hypertriglyceridaemia, hypercholesterolaemia and dyslipidaemia
ARP040102230A AR044909A1 (es) 2003-06-25 2004-06-25 Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia
ZA200600690A ZA200600690B (en) 2003-06-25 2006-01-24 Thiazolylpiperidine derivatives as MTP inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0307670A FR2856685B1 (fr) 2003-06-25 2003-06-25 Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FR2856685A1 FR2856685A1 (fr) 2004-12-31
FR2856685B1 true FR2856685B1 (fr) 2005-09-23

Family

ID=33515396

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0307670A Expired - Fee Related FR2856685B1 (fr) 2003-06-25 2003-06-25 Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (18)

Country Link
US (1) US7674803B2 (fr)
EP (1) EP1636218B1 (fr)
JP (1) JP4629666B2 (fr)
KR (1) KR20060024812A (fr)
CN (1) CN1809560A (fr)
AR (1) AR044909A1 (fr)
AT (1) ATE426599T1 (fr)
AU (1) AU2004253649B2 (fr)
BR (1) BRPI0411721A (fr)
CA (1) CA2531011C (fr)
DE (1) DE602004020223D1 (fr)
ES (1) ES2323463T3 (fr)
FR (1) FR2856685B1 (fr)
MX (1) MXPA05013521A (fr)
RU (1) RU2006101890A (fr)
TW (1) TW200518751A (fr)
WO (1) WO2005003128A1 (fr)
ZA (1) ZA200600690B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865733B1 (fr) * 2004-02-04 2007-10-12 Merck Sante Sas Derives de thiazolylimidazole, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en medecine
NZ553734A (en) * 2004-09-20 2011-01-28 4Sc Ag Novel thiazole derivatives as NF-kappaB inhibitors
EP1637529A1 (fr) 2004-09-20 2006-03-22 4Sc Ag Nouveaux analogues de piperidin-4-yl-thiazole-carboxamide en tant qu'inhibiteurs de proliferation de lymphocytes T er leurs utilisations
US20100267717A1 (en) * 2005-07-29 2010-10-21 4Sc Ag Novel Heterocyclic NF-kB Inhibitors
US7601745B2 (en) 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
SG172738A1 (en) * 2005-07-29 2011-07-28 4Sc Ag Novel heterocyclic nf-kb inhibitors
AU2006281435A1 (en) * 2005-08-18 2007-02-22 F. Hoffmann-La Roche Ag Thiazolyl piperidine derivatives useful as H3 receptor modulators
EP1832586A1 (fr) * 2006-03-10 2007-09-12 Oridis Biomed Forschungs- und Entwicklungs GmbH Derivés de thiazole-piperidine pour le traitement des des maladies hepatiques et pancréatiques
EP1834954A1 (fr) * 2006-03-15 2007-09-19 4Sc Ag Thiazoles comme inhibiteurs de NF-kB (inhibiteurs de proteasome)
AU2007224659A1 (en) * 2006-03-15 2007-09-20 4Sc Ag Novel heterocyclic NF-KB inhibitors
WO2007115805A2 (fr) * 2006-04-05 2007-10-18 European Molecular Biology Laboratory (Embl) Inhibiteurs de la kinase aurora
JP5182088B2 (ja) * 2006-04-19 2013-04-10 アステラス製薬株式会社 アゾールカルボキサミド誘導体
DK3421471T3 (da) 2006-04-25 2021-06-14 Astex Therapeutics Ltd Purin- og deazapurinderivater som farmaceutiske forbindelser
US9090604B2 (en) 2006-07-27 2015-07-28 E I Du Pont De Nemours And Company Fungicidal azocyclic amides
WO2008013622A2 (fr) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Amides azocycliques fongicides
EP2078004B1 (fr) * 2006-10-31 2015-02-25 Merck Sharp & Dohme Corp. Amides d'acides 2-aminothiazole-4-carboxyliques utilisées comme inhibiteurs de protéines kinases
WO2008054702A1 (fr) * 2006-10-31 2008-05-08 Schering Corporation Dérivés d'anilinopipérazine et leurs méthodes d'utilisation
CN101663262B (zh) * 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
PE20081559A1 (es) 2007-01-12 2008-11-20 Merck & Co Inc DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
US8420673B2 (en) 2007-01-25 2013-04-16 E I Du Pont De Nemours And Company Fungicidal amides
DE102007047735A1 (de) * 2007-10-05 2009-04-09 Merck Patent Gmbh Thiazolderivate
PL2201012T3 (pl) 2007-10-11 2014-11-28 Astrazeneca Ab Pochodne pirolo[2,3-d]pirymidyny jako inhibitory kinazy białkowej b
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
EP2206707B1 (fr) 2007-10-24 2014-07-23 Astellas Pharma Inc. Composé à base d'azolecarboxamide ou son sel
EP2212318B1 (fr) * 2007-10-29 2013-07-24 Merck Sharp & Dohme Corp. Dérivés de thiazole et leurs procédés d'utilisation
CN101970432B (zh) * 2008-01-25 2014-05-28 杜邦公司 杀真菌杂环化合物
MX2010011879A (es) 2008-04-30 2010-12-06 Bayer Cropscience Ag Esteres y tioesteres del acido tiazol-4-carboxilico como agentes fitoprotectores.
BRPI0920767B1 (pt) * 2008-10-01 2018-07-17 Bayer Intellectual Property Gmbh tiazóis substituídos por heterociclila como agentes protetores de cultura, seus usos e seus processos de preparação, composições e seu processo de preparação, e método para combate a fungos nocivos fitopatogênicos
TW201036966A (en) 2008-12-02 2010-10-16 Du Pont Fungicidal heterocyclic compounds
JP5642661B2 (ja) * 2009-03-05 2014-12-17 塩野義製薬株式会社 Ｎｐｙｙ５受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
EP2272846A1 (fr) * 2009-06-23 2011-01-12 Bayer CropScience AG Dérivés de thiazolylpipéridine en tant que fongicide
KR20120089644A (ko) * 2009-08-12 2012-08-13 신젠타 파티서페이션즈 아게 살미생물성 헤테로사이클
WO2011051243A1 (fr) 2009-10-29 2011-05-05 Bayer Cropscience Ag Combinaisons de composé actif
EP2493886B1 (fr) 2009-10-30 2014-11-26 Bayer CropScience AG Dérivés d'hétéroaryl pipéridine et pipérazine
EP2516424B1 (fr) * 2009-12-22 2013-12-18 Syngenta Participations AG Dérivés de pyrazole
JP5960683B2 (ja) * 2010-04-28 2016-08-02 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 殺真菌剤としてのケトヘテロアリールピペリジンおよび−ピペラジン誘導体
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8815775B2 (en) * 2010-05-18 2014-08-26 Bayer Cropscience Ag Bis(difluoromethyl)pyrazoles as fungicides
KR101848116B1 (ko) 2011-02-01 2018-04-11 바이엘 인텔렉쳐 프로퍼티 게엠베하 살진균제로서의 헤테로아릴 피페리딘 및 헤테로아릴 피페라진 유도체
KR101923367B1 (ko) 2011-02-02 2018-12-04 버텍스 파마슈티칼스 인코포레이티드 이온 채널의 조절제로서의 피롤로피라진―스피로사이클릭 피페리딘 아미드
WO2012107477A1 (fr) * 2011-02-10 2012-08-16 Syngenta Participations Ag Dérivés de pyrazole microbiocides
MX2013009393A (es) * 2011-02-18 2013-08-29 Vertex Pharma Piperidinamidas cromano-espirociclicas como moduladores de canales de iones.
CN103517910B (zh) 2011-03-14 2016-12-14 沃泰克斯药物股份有限公司 作为离子通道调节剂的吗啉-螺环哌啶酰胺
EA027506B1 (ru) 2011-04-01 2017-08-31 Астразенека Аб Способ лечения рака молочной железы
HRP20191982T4 (hr) 2011-11-30 2023-01-06 Astrazeneca Ab Kombinacijsko liječenje raka
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
WO2015018027A1 (fr) 2013-08-08 2015-02-12 Merck Sharp & Dohme Corp. Antagonistes thiazoles des récepteurs de l'orexine
WO2016086357A1 (fr) * 2014-12-02 2016-06-09 Merck Sharp & Dohme Corp. Méthyl oxazoles antagonistes du récepteur d'orexine
EP3573619A4 (fr) * 2017-01-27 2020-10-28 SignalRX Pharmaceuticals, Inc. Thiénopyranones et furanopyranones en tant qu'inhibiteurs de kinase, de bromodomaine et de points de contrôle
EP3615087B1 (fr) * 2017-04-28 2023-09-06 Texas Children's Hospital Ciblage de nanoparticules
CN111196805A (zh) * 2018-11-17 2020-05-26 曲阜德禄生物科技有限公司 哌啶基噻唑甲酰胺类化合物合成方法与用途
CN113966337B (zh) * 2020-05-12 2024-01-02 北京广为医药科技有限公司 调节nmda受体活性的化合物、其药物组合物及用途
CA3185209A1 (fr) * 2020-07-10 2021-01-27 Alyssa WINKLER Inhibiteurs de gas41 et leurs methodes d'utilisation
CN120917015A (zh) * 2023-01-20 2025-11-07 元启(苏州)生物制药有限公司 Srpk1抑制剂和使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11513382A (ja) * 1995-10-20 1999-11-16 ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング ５員複素環化合物、これらの化合物を含む医薬品、それらの使用及びそれらの調製方法
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
DE60139382D1 (de) * 2000-04-04 2009-09-10 Smithkline Beecham Plc 2-hydroxy-mutilin-carbamat derivate und ihre anwendung als antibakterielle mittel
FR2816940A1 (fr) * 2000-11-23 2002-05-24 Lipha Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation
GB0129013D0 (en) * 2001-12-04 2002-01-23 Glaxo Group Ltd Compounds
GB0230162D0 (en) * 2002-12-24 2003-02-05 Metris Therapeutics Ltd Compounds useful in inhibiting angiogenesis

Also Published As

Publication number Publication date
CA2531011A1 (fr) 2005-01-13
JP2007506651A (ja) 2007-03-22
WO2005003128A1 (fr) 2005-01-13
AU2004253649A1 (en) 2005-01-13
CN1809560A (zh) 2006-07-26
KR20060024812A (ko) 2006-03-17
JP4629666B2 (ja) 2011-02-09
ZA200600690B (en) 2007-05-30
AU2004253649B2 (en) 2009-09-24
US20070054939A1 (en) 2007-03-08
AR044909A1 (es) 2005-10-05
ATE426599T1 (de) 2009-04-15
ES2323463T3 (es) 2009-07-16
BRPI0411721A (pt) 2006-05-23
DE602004020223D1 (de) 2009-05-07
CA2531011C (fr) 2012-10-09
RU2006101890A (ru) 2007-07-27
EP1636218B1 (fr) 2009-03-25
TW200518751A (en) 2005-06-16
EP1636218A1 (fr) 2006-03-22
MXPA05013521A (es) 2006-03-09
US7674803B2 (en) 2010-03-09
FR2856685A1 (fr) 2004-12-31

Similar Documents

Publication Publication Date Title
FR2856685B1 (fr) Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2871463B1 (fr) Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
EP1435894A4 (fr) Composes cytoprotecteurs, procedes et formulations pharmaceutiques et cosmetiques
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
HUP0402161A3 (en) Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them
FR2816938B1 (fr) Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
FR2852954B1 (fr) Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
IL169818A0 (en) Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
EE05304B1 (et) Aminokinoliini derivaadid, meetod nende valmistamiseks, neid sisaldavad ravimkoostised ja nende kasutamine adenosiini A3-retseptori ligandidena
FR2858619B1 (fr) Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2867472B1 (fr) Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
EP1911761A4 (fr) Derives d'artemisinine hydrosolubles, leurs procedes de preparation, leurs compositions pharmaceutiques et leur utilisation
IL174135A0 (en) Benzimidazole acetonitrile derivatives, their preparation and and pharmaceutical compositions containing them
ATE398109T1 (de) 4-pyrimidinamine derivate, pharmazeutische zusammenstellungen und verwandte methoden
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
FR2865733B1 (fr) Derives de thiazolylimidazole, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en medecine
FR2842525B1 (fr) Derives de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments et compositions pharmaceutiques les renfermant
FR2883876B1 (fr) Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE0300457D0 (sv) Novel compounds
SI1590314T1 (sl) 2-aril-ocetne kisline, njihovi derivati in farmacevtski sestavki, ki jih vsebujejo
FR2819508B1 (fr) Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080229